These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38753856)

  • 1. Navigating regulatory landscape: A qualitative exploration of medical devices and in vitro diagnostic medical devices oversight in Zimbabwe through key stakeholder perspectives.
    Chiku C; Maruta T; Mbiba F; Manasa J
    PLoS One; 2024; 19(5):e0287415. PubMed ID: 38753856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing operational readiness: Regulatory landscape and compliance in zimbabwe for medical devices and in vitro diagnostic medical devices.
    Chiku C; Maruta T; Mbiba F; Manasa J
    PLoS One; 2024; 19(5):e0287495. PubMed ID: 38753597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of HIV self-testing in Malawi, Zambia and Zimbabwe: a qualitative study with key stakeholders.
    Dacombe RJ; Watson V; Nyirenda L; Madanhire C; Simwinga M; Chepuka L; Johnson CC; Corbett EL; Hatzold K; Taegtmeyer M
    J Int AIDS Soc; 2019 Mar; 22 Suppl 1(Suppl Suppl 1):e25229. PubMed ID: 30907513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of medical diagnostics and medical devices in the East African community partner states.
    Rugera SP; McNerney R; Poon AK; Akimana G; Mariki RF; Kajumbula H; Kamau E; Mpawenimana S; Said SY; Toroitich A; Ronoh W; Sollis KA; Sonoiya S; Peeling RW
    BMC Health Serv Res; 2014 Oct; 14():524. PubMed ID: 25366990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the registration process of the medicines control authority of Zimbabwe with Australia, Canada, Singapore, and Switzerland: benchmarking best practices.
    Sithole T; Salek S; Mahlangu G; Walker S
    Expert Rev Clin Pharmacol; 2022 Jan; 15(1):109-119. PubMed ID: 34645359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and Opportunities.
    Sithole T; Mahlangu G; Salek S; Walker S
    Ther Innov Regul Sci; 2021 May; 55(3):474-489. PubMed ID: 33387356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of medical devices and in vitro diagnostics in resource-limited settings.
    Mori M; Ravinetto R; Jacobs J
    Trop Med Int Health; 2011 Nov; 16(11):1439-49. PubMed ID: 21955331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco is "our industry and we must support it": Exploring the potential implications of Zimbabwe's accession to the Framework Convention on Tobacco Control.
    Lown EA; McDaniel PA; Malone RE
    Global Health; 2016 Jan; 12():2. PubMed ID: 26754965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal regulation of the production and trade of medical devices and medical equipment in the EU and US: experience for Ukraine.
    Pashkov V; Kotvitska A; Harkusha A
    Wiad Lek; 2017; 70(3 pt 2):614-618. PubMed ID: 28713093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries.
    Roth L; Nalim A; Turesson B; Krech L
    Global Health; 2018 Apr; 14(1):43. PubMed ID: 29695278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access and reimbursement pathways for digital health solutions and
    Mantovani A; Leopaldi C; Nighswander CM; Di Bidino R
    Front Med Technol; 2023; 5():1101476. PubMed ID: 36891483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety of high risk in vitro diagnostic medical devices : international and national measures].
    Halbauer J; Siekmeier R; Funk M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jun; 52(6):610-8. PubMed ID: 19421725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new European directive on in vitro diagnostics.
    Dati F
    Clin Chem Lab Med; 2003 Oct; 41(10):1289-98. PubMed ID: 14580154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with post-market surveillance of in-vitro diagnostic medical devices for lay use in Germany.
    Siekmeier R; Lütz J
    Clin Chem Lab Med; 2007; 45(3):396-401. PubMed ID: 17378740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of blood-screening
    Abdurrahman G; Samukange W; Lyoko N; Shonhiwa NO; Kafere C; Nübling CM; Peeling RW; Reinhardt J
    Front Med (Lausanne); 2023; 10():1252721. PubMed ID: 37854664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978-2020.
    Fimbo AM; Sillo HB; Nkayamba A; Kisoma S; Mwalwisi YH; Idris R; Asiimwe S; Githendu P; Ogbuoji O; Morrison L; Bump JB; Kaale E
    PLOS Glob Public Health; 2024; 4(10):e0003241. PubMed ID: 39413119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health system lessons from the global fund-supported procurement and supply chain investments in Zimbabwe: a mixed methods study.
    Lesego A; Were LPO; Tsegaye T; Idris R; Morrison L; Peterson T; Elhussein S; Antonio E; Magwindiri G; Dumba I; Mtambirwa C; Madzikwa N; Simbi R; Ndlovu M; Achoki T
    BMC Health Serv Res; 2024 May; 24(1):557. PubMed ID: 38693548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.